SOLIGENIX, INC. — Director's Dealing 2009

Jul 9, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-06-04

Reporting Person: KUO JAMES S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-06-04	Stock Option (right to buy)	$.14	A	250000	Acquired	2019-06-03	Common Stock (250000)	Direct

Footnotes

F1: Stock Options awarded for re-election to Board of Directors.